2018
Repint of “Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity”
Tordjman S, Cohen D, Anderson G, Botbol M, Canitano R, Coulon N, Roubertoux P. Repint of “Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity”. Neuroscience & Biobehavioral Reviews 2018, 89: 132-150. PMID: 29391184, DOI: 10.1016/j.neubiorev.2018.01.014.Peer-Reviewed Original ResearchConceptsCognitive-behavioral phenotypeMental disordersAutism spectrum disorderPossible common underlying mechanismNon-categorical approachAutism phenotypeBehavioral syndromeNon-syndromic autismSpectrum disorderDevelopmental trajectoriesAutismSpecific mental disordersCommon underlying mechanismSyndromic autismDiverse genetic disordersEtiological heterogeneityDisordersClinical genetic examinationUnknown disorder
2017
Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity
Tordjman S, Cohen D, Coulon N, Anderson G, Botbol M, Canitano R, Roubertoux P. Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity. Neuroscience & Biobehavioral Reviews 2017, 80: 210. PMID: 28153685, DOI: 10.1016/j.neubiorev.2017.01.030.Peer-Reviewed Original ResearchCognitive-behavioral phenotypeMental disordersAutism spectrum disorderPossible common underlying mechanismNon-categorical approachAutism phenotypeBehavioral syndromeNon-syndromic autismSpectrum disorderDevelopmental trajectoriesAutismSpecific mental disordersCommon underlying mechanismSyndromic autismDiverse genetic disordersEtiological heterogeneityDisordersClinical genetic examinationUnknown disorder
1993
Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism
Narayan M, Srinath S, Anderson G, Meundi DB. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biological Psychiatry 1993, 33: 630-635. PMID: 7687150, DOI: 10.1016/0006-3223(93)90102-j.Peer-Reviewed Original ResearchConceptsCSF homovanillic acidHomovanillic acidCerebrospinal fluid concentrationsCerebrospinal fluid levelsDopamine turnoverDopamine metabolitesCentral serotoninControl groupFluid levelsFluid concentrationsMarked alterationsGroup differencesAutistic disorderAutistic subjectsSerotoninChildrenAutistic childrenAlterationsGroupAutismPrevious studies
1982
Clinical neurochemistry of autism and associated disorders
Young J, Kavanagh M, Anderson G, Shaywitz B, Cohen D. Clinical neurochemistry of autism and associated disorders. Journal Of Autism And Developmental Disorders 1982, 12: 147-165. PMID: 6184361, DOI: 10.1007/bf01531305.Peer-Reviewed Original ResearchConceptsNorepinephrine metabolismNeurochemical methodsClinical neurochemistryClinical studiesNeurochemical studiesBehavioral deficitsBiochemical dysfunctionBrain functionAutistic syndromeInfantile autismLow levelsNew studiesAutismDysfunctionSerotoninSyndromeAutistic individualsSymptomsNeurochemistryBrainMajor obstacle